Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen P Hunger

Showing results (251-260 of 346) with videos related to

Pageof 35
Sort By:
Leukemia|March 25, 2023
Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932Reuven J Schore, Anne L Angiolillo, John A Kairalla, et al.
Leukemia|May 8, 2023
Correction: Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932Reuven J Schore, Anne L Angiolillo, John A Kairalla, et al.
Cancer|October 30, 2019
Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task ForceEtan Orgel, Thomas B Alexander, Brent L Wood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2021
Favorable Trisomies and <i>ETV6-RUNX1</i> Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331Leonard A Mattano, Meenakshi Devidas, Kelly W Maloney, et al.
Blood|December 5, 2021
Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell-like blasts in KMT2A-rearranged leukemiaChangya Chen, Wenbao Yu, Fatemeh Alikarami, et al.
Blood|September 26, 2012
Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemiaJun J Yang, Cheng Cheng, Meenakshi Devidas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2020
Reduced Morbidity and Mortality in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor StudyStephanie B Dixon, Yan Chen, Yutaka Yasui, et al.
Haematologica|June 13, 2024
Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed <i>KMT2A</i>-rearranged acute lymphoblastic leukemia: Children's Oncology Group trial AALL15P1Erin M Guest, John A Kairalla, Meenakshi Devidas, et al.
Nature|March 25, 2015
Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemiaZhengshan Chen, Seyedmehdi Shojaee, Maike Buchner, et al.
Haematologica|March 2, 2023
<i>KMT2A</i> partner genes in infant acute lymphoblastic leukemia have prognostic significance and correlate with age, white blood cell count, sex, and central nervous system involvement: a Children's Oncology Group P9407 trial studyBlaine W Robinson, John A Kairalla, Meenakshi Devidas, et al.
Pageof 35

Showing results (251-260 of 346) with videos related to

Sort By:
Pageof 35
Leukemia|March 25, 2023
Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932Reuven J Schore, Anne L Angiolillo, John A Kairalla, et al.
Leukemia|May 8, 2023
Correction: Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932Reuven J Schore, Anne L Angiolillo, John A Kairalla, et al.
Cancer|October 30, 2019
Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task ForceEtan Orgel, Thomas B Alexander, Brent L Wood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2021
Favorable Trisomies and <i>ETV6-RUNX1</i> Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331Leonard A Mattano, Meenakshi Devidas, Kelly W Maloney, et al.
Blood|December 5, 2021
Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell-like blasts in KMT2A-rearranged leukemiaChangya Chen, Wenbao Yu, Fatemeh Alikarami, et al.
Blood|September 26, 2012
Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemiaJun J Yang, Cheng Cheng, Meenakshi Devidas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2020
Reduced Morbidity and Mortality in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor StudyStephanie B Dixon, Yan Chen, Yutaka Yasui, et al.
Haematologica|June 13, 2024
Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed <i>KMT2A</i>-rearranged acute lymphoblastic leukemia: Children's Oncology Group trial AALL15P1Erin M Guest, John A Kairalla, Meenakshi Devidas, et al.
Nature|March 25, 2015
Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemiaZhengshan Chen, Seyedmehdi Shojaee, Maike Buchner, et al.
Haematologica|March 2, 2023
<i>KMT2A</i> partner genes in infant acute lymphoblastic leukemia have prognostic significance and correlate with age, white blood cell count, sex, and central nervous system involvement: a Children's Oncology Group P9407 trial studyBlaine W Robinson, John A Kairalla, Meenakshi Devidas, et al.
Pageof 35